key: cord-0712084-q8tnw9qd
authors: Diamond, Laura M.; Clarfield, Lauren E.; Forte, Milena
title: Vaccinations against human papillomavirus missed because of COVID-19 may lead to a rise in preventable cervical cancer
date: 2021-09-20
journal: CMAJ
DOI: 10.1503/cmaj.80082
sha: 0c160101052a4c07dcae6b88c215c4eeff4d78fb
doc_id: 712084
cord_uid: q8tnw9qd

nan

As a result of the COVID-19 pandemic and the subsequent disruptions to in-person classes, school-based vaccination programs against human papillomavirus (HPV), hepatitis B and meningococcal meningitis were cancelled across the country. Although there have been catch-up vaccination clinics in Canada, uptake is low. These clinics rely on personal initiative and knowledge of their existence; thus, they perpetuate vaccination dispar ities that the school-based programs in itially set out to break down. 1 There is currently no plan in place in most jurisdictions for a widespread vaccination program of students who were in grade 7 in 2019/2020 and 2020/2021.

In country-wide, registry-based studies of > 1 million participants, the HPV vaccine has been shown to be extremely effective in reducing the prevalence of cervical cancer. 2,3 An increased incidence of cervical cancer in future years as a consequence of the COVID-19 pandemic would be devastating. Canadian provinces urgently need to arrange catch-up HPV vaccination programs for cohorts of students who have missed receiving their vaccines in school.

Adequate catch-up vaccination is unlikely to happen without a coordinated, school-based approach. School-based, publicly funded vaccination programs have been associated with a substantial increase in uptake of HPV vaccines in Canada, with individuals who have access to school-based programs 3.73 times more likely to get vaccinated. 4 In addition, school-based vaccination programs allow for more equitable vaccine uptake among those living in low-income neighbourhoods. 5 This is especially important given the well-established increased burden of cervical cancer and reduced cervical cancer screening in low-income communities. 5, 6 Furthermore, students lose eligibility for free HPV vaccination once they graduate from high school. This can mean up to $500 in out-of-pocket costs for unvaccinated high school graduates seeking a 3-dose vaccine series, serving as an additional barrier to vaccination. 4, 7 Ideally, a catch-up vaccination plan should be formalized and should include a clear communication strategy to families, explaining that key vaccinations have been missed, and the implications of this. The plan should include outreach to the parents and health care providers of students who were in grade 7 in 2019/2020 and 2020/2021 to ensure they are aware of the child's current HPV vaccination status. 

Toronto Public Health expands programs to support a safe return to school

Large study confirms that HPV vaccine prevents cervical cancer

National Cancer Institute

Very low prevalence of vaccine human papillomavirus types among 18-to 35-year old Australian women 9 years following implementation of vaccination

Human papillomavirus vaccination uptake in Canada: a systematic review and meta-analysis

Costeffectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand

Cervical cancer screening rates below provincial target, vary with neighbourhood income. Toronto: Cancer Care Ontario

Human papillomavirus (HPV) vaccine fact sheet

Content licence: This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/ licenses/by-nc-nd/4.0/